Zenith_AGM_2018_09_1... (rough)
|
8
|
Zenith Epigenetics
|
Sep 20, 2018 09:28AM
|
Zenith question but also reflects on Mgmt decisions
|
5
|
Resverlogix Corp.
|
May 31, 2021 12:33PM
|
Zenith Meeting audio?
|
1
|
Zenith Epigenetics
|
Nov 13, 2019 04:14AM
|
Zenith Epigenetics did not respond to invitatations in this one
|
3
|
Zenith Epigenetics
|
May 31, 2021 12:00PM
|
Zenith Epigenetics 150513 Conf Call
|
2
|
Resverlogix Corp.
|
May 20, 2015 02:18PM
|
Zenith Epigenetics 1407__ Epicongress Boston July 2014
|
1
|
Resverlogix Corp.
|
May 20, 2015 02:15PM
|
Zenith Epigenetics 140220 Webcast
|
3
|
Resverlogix Corp.
|
May 20, 2015 02:01PM
|
Zenith Epigenetics 130908 Rodman and Renshaw
|
3
|
Resverlogix Corp.
|
May 20, 2015 01:59PM
|
Wish they would get in on this type of thing
|
2
|
Resverlogix Corp.
|
Sep 25, 2021 07:02PM
|
While we wait, outside items that may be of interest
|
2
|
Resverlogix Corp.
|
Aug 22, 2017 05:32PM
|
Veterinary Applications?
|
5
|
Zenith Epigenetics
|
Aug 06, 2017 04:49AM
|
Very Off Topic but still of interest for animal lovers and some people
|
|
Resverlogix Corp.
|
Aug 29, 2016 05:43PM
|
Various refs on COVID as a vascular /vascular endothelial disease
|
1
|
Resverlogix Corp.
|
Nov 13, 2020 09:28PM
|
Unrelated but interesting - a drug shown to improve eGFR in patients with Alports- wonder if there is any synergy potential here
|
|
Resverlogix Corp.
|
Nov 09, 2020 06:54PM
|
UNOFFICIAL - Transcript of May 13 Zenith Conf Call
|
5
|
Resverlogix Corp.
|
May 19, 2015 10:45PM
|
Types of FDA meetings
|
4
|
Resverlogix Corp.
|
Aug 03, 2022 02:50PM
|
Two on COVID and kidneys
|
6
|
Resverlogix Corp.
|
Sep 30, 2020 07:01PM
|
Two more general articles for today
|
|
Resverlogix Corp.
|
Apr 09, 2021 12:28AM
|
Two Interesting Articles: - 1 of 2 Developing Covid-19 Vaccines at Pandemic Speed
|
1
|
Resverlogix Corp.
|
Apr 13, 2020 04:54PM
|
Two Interesting Articles - 2 of 2: COVID-19: consider cytokine storm syndromes and immunosuppression
|
4
|
Resverlogix Corp.
|
Apr 13, 2020 05:01PM
|